Home › CytomX IPO Could Pop, But Long-Term Returns Are Uncertain
 

Keywords :   


CytomX IPO Could Pop, But Long-Term Returns Are Uncertain

2015-10-07 21:20:52| Biotech - Topix.net

CytomX Therapeutics expects to raise $100 million in its upcoming IPO. Based in South San Francisco, California, CytomX Therapeutics is a biopharmaceutical company focused on developing treatments for cancer.

Tags: pop returns ipo uncertain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.1146 4th year birthdayLive DVD
26.11 LCD
26.11gtk
26.111/28 B-24D LIBERATOR
26.11seventeen SPILL THE FEELS standard
26.11
26.11 21 12
26.11lululemon
More »